KYORIN Pharmaceutical Co.,Ltd. 4569Short Interest

Estimated short interest in KYORIN Pharmaceutical Co.,Ltd. (4569) is 1.14% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, MERRILL LYNCH INTERNATIONAL.

Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Estimated short interest
1.14%
±0.00%
Estimated position (shares)
688,575
As of 2026-11-18
Holders (0.5% or more)
2 firms
87 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (0.54% in total). It also excludes 6 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2018-11-30
Latest disclosure2026-11-16 (GOLDMAN SACHS INTERNATIONAL, 0.49%)
Reporting institutions11 firms (87 reports)
Peak estimated short interest1.84% (2026-06-25, 3 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • Barclays Capital Securities Ltd
  • MERRILL LYNCH INTERNATIONAL
  • Citigroup Global Markets Limited
  • GOLDMAN SACHS INTERNATIONAL
  • Daiwa Securities Co. Ltd.
1.14%
Estimated short interest, 2026-11-18
MERRILL LYNCH INTERNATIONAL0.52%
Barclays Capital Securities Ltd0.62%

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2026-11-04 Barclays Capital Securities Ltd Position 375,200 shares Ratio 0.62% ▲0.15% +92,000 Holding
2018-11-30 Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP   Position 355,300 shares Ratio 0.54% ▲0.08% No report for 1+ year
2026-11-13 MERRILL LYNCH INTERNATIONAL Position 313,375 shares Ratio 0.52% ▲0.01% +6,000 Holding
2021-05-31 UBS AG Position 317,900 shares Ratio 0.49% ▼0.02% +142,000 Below 0.5%
2026-06-05 Daiwa Securities Co. Ltd. Position 297,561 shares Ratio 0.49% ▼0.01% −2,800 Below 0.5%
2026-11-16 GOLDMAN SACHS INTERNATIONAL Position 293,884 shares Ratio 0.49% ▼0.10% −61,400 Below 0.5%
2019-07-02 Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP Position 288,735 shares Ratio 0.45% ▼0.10% Below 0.5%
2020-03-11 Morgan Stanley MUFG Securities Co., Ltd. Position 287,169 shares Ratio 0.44% ▼0.10% −66,800 Below 0.5%
2018-12-21 Integrated Core Strategies (Asia) Pte. Ltd. Position 212,700 shares Ratio 0.32% ▼0.18% −112,000 Below 0.5%
2019-12-10 Credit Suisse AG Position 0 shares Ratio 0.00% ▼0.78% ±0 Closed
2026-08-31 Citigroup Global Markets Limited Position 0 shares Ratio 0.00% ▼1.10% −663,598 Closed

Disclosure History 87 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-11-16 GOLDMAN SACHS INTERNATIONAL Position 293,884 shares Ratio 0.49% ▼0.10% −61,400 Below 0.5%
2026-11-13 MERRILL LYNCH INTERNATIONAL Position 313,375 shares Ratio 0.52% ▲0.01% +6,000 —
2026-11-12 MERRILL LYNCH INTERNATIONAL Position 307,375 shares Ratio 0.51% ▼0.01% −10,100 —
2026-11-11 MERRILL LYNCH INTERNATIONAL Position 317,475 shares Ratio 0.52% ▲0.01% +7,200 —
2026-11-10 MERRILL LYNCH INTERNATIONAL Position 310,275 shares Ratio 0.51% ▼0.01% −3,800 —
2026-11-06 MERRILL LYNCH INTERNATIONAL Position 314,075 shares Ratio 0.52% ▼0.01% −9,200 —
2026-11-05 GOLDMAN SACHS INTERNATIONAL Position 355,284 shares Ratio 0.59% ▼0.09% −53,600 —
2026-11-04 MERRILL LYNCH INTERNATIONAL Position 323,275 shares Ratio 0.53% ▼0.01% −800 —
2026-11-04 Barclays Capital Securities Ltd Position 375,200 shares Ratio 0.62% ▲0.15% +92,000 —
2026-10-30 MERRILL LYNCH INTERNATIONAL Position 324,075 shares Ratio 0.54% ▼0.01% −5,700 —
2026-10-29 MERRILL LYNCH INTERNATIONAL Position 329,775 shares Ratio 0.55% ▲0.02% +6,456 —
2026-10-29 GOLDMAN SACHS INTERNATIONAL Position 408,884 shares Ratio 0.68% ▼0.03% −22,300 —
2026-10-29 Barclays Capital Securities Ltd Position 283,200 shares Ratio 0.47% ▼0.08% −52,300 Below 0.5%
2026-10-28 MERRILL LYNCH INTERNATIONAL Position 323,319 shares Ratio 0.53% ▲0.02% +12,900 —
2026-10-28 GOLDMAN SACHS INTERNATIONAL Position 431,184 shares Ratio 0.71% ▲0.02% +12,200 —
2026-10-28 Barclays Capital Securities Ltd Position 335,500 shares Ratio 0.55% ▼0.05% −29,000 —
2026-10-27 MERRILL LYNCH INTERNATIONAL Position 310,419 shares Ratio 0.51% ▲0.02% +14,700 —
2026-10-21 MERRILL LYNCH INTERNATIONAL Position 295,719 shares Ratio 0.49% ▼0.03% −18,444 Below 0.5%
2026-10-20 MERRILL LYNCH INTERNATIONAL Position 314,163 shares Ratio 0.52% ▲0.01% +7,000 —
2026-10-19 GOLDMAN SACHS INTERNATIONAL Position 418,984 shares Ratio 0.69% ▼0.01% −2,000 —
2026-10-16 MERRILL LYNCH INTERNATIONAL Position 307,163 shares Ratio 0.51% ▼0.02% −16,100 —
2026-10-15 GOLDMAN SACHS INTERNATIONAL Position 420,984 shares Ratio 0.70% ▲0.02% +8,600 —
2026-10-13 MERRILL LYNCH INTERNATIONAL Position 323,263 shares Ratio 0.53% ▲0.02% +16,500 —
2026-10-09 GOLDMAN SACHS INTERNATIONAL Position 412,384 shares Ratio 0.68% ▼0.02% −10,400 —
2026-10-08 MERRILL LYNCH INTERNATIONAL Position 306,763 shares Ratio 0.51% ▲0.01% +5,000 —
2026-10-07 MERRILL LYNCH INTERNATIONAL Position 301,763 shares Ratio 0.50% ▲0.01% +6,220 —
2026-10-05 GOLDMAN SACHS INTERNATIONAL Position 422,784 shares Ratio 0.70% ▲0.07% +39,300 —
2026-10-02 Barclays Capital Securities Ltd Position 364,500 shares Ratio 0.60% ▲0.10% +61,200 —
2026-10-01 GOLDMAN SACHS INTERNATIONAL Position 383,484 shares Ratio 0.63% ▲0.13% +82,800 —
2026-09-28 Barclays Capital Securities Ltd Position 303,300 shares Ratio 0.50% ▲0.08% +17,600 —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
ZERIA PHARMACEUTICAL CO.,LTD.4559 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
AnGes,Inc.4563 Growth Market(Domestic) Pharmaceutical Pharmaceutical
OncoTherapy Science,Inc.4564 Growth Market(Domestic) Pharmaceutical Pharmaceutical
Nxera Pharma Co.,Ltd.4565 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
DAIICHI SANKYO COMPANY,LIMITED4568 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Core30
Immuno-Biological Laboratories Co.,Ltd.4570 Growth Market(Domestic) Pharmaceutical Pharmaceutical
Nano Holdings,Inc.4571 Growth Market(Domestic) Pharmaceutical Pharmaceutical
Carna Biosciences,Inc.4572 Growth Market(Domestic) Pharmaceutical Pharmaceutical
TAIKO PHARMACEUTICAL CO.,LTD.4574 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
CanBas Co.,Ltd.4575 Growth Market(Domestic) Pharmaceutical Pharmaceutical